BeOne Medicines has signed a multi-part collaboration with Revolution Medicines to develop and commercialise targeted oncology therapies. The deal includes joint studies combining BeOne's cancer pipeline assets with four clinical-stage RAS(ON) inhibitors from Revolution Medicines, alongside a…
Want to know the latest news and articles posted on AllToc News?
Then subscribe to their feed now! You can receive their updates by email, via mobile or on your personal news page on this website.
See what they recently published below.
Website title: BizToc